NAD+ precursors: what NMN and NR are and how they work

NAD+: a coenzyme at the center of metabolism

NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme found in every living cell. A coenzyme is a small helper molecule that many enzymes require in order to carry out their chemical work; without it, those enzymes cannot function. NAD+ is among the most abundant and heavily used coenzymes in human metabolism, and it is built from building blocks in the vitamin B3, or niacin, family of nutrients.

The best-understood role of NAD+ is in reduction-oxidation, or "redox," chemistry — the transfer of electrons from one molecule to another. NAD+ exists in two interconverting forms: an oxidized form (NAD+) that can accept electrons and a reduced form (NADH) that carries them. By cycling between these two states, the molecule acts as a shuttle, picking up electrons released as nutrients are broken down and delivering them elsewhere. This shuttling runs through the central pathways of energy metabolism, including glycolysis, the citric acid (Krebs) cycle, and the electron transport chain that cells use to extract chemical energy from food.

Because it participates in so many reactions, NAD+ is often described as a hub of cellular metabolism rather than a molecule with a single job. This article describes that biology at a general level. It is educational only, is not medical advice, and does not describe NMN, NR, or NAD+ itself as a treatment for any condition.

More than energy: NAD+ as a signaling substrate

Redox chemistry is only part of the picture. NAD+ also serves as a substrate — a raw material that certain enzymes consume and break apart rather than simply borrow. One well-studied family of these enzymes is the sirtuins, which use NAD+ as a co-substrate when they remove chemical tags from proteins. Through that activity, sirtuins are involved in processes such as gene regulation and the way cells respond to metabolic conditions, and their dependence on NAD+ links their activity to the cell's supply of the coenzyme.

Other NAD+-consuming enzymes include the PARPs, which are associated with DNA repair and stress responses, and CD38, an enzyme involved in immune signaling and other functions. Each of these enzymes cleaves NAD+ as part of its normal activity, releasing nicotinamide as a byproduct in the process. Because this consumption is continuous, the cell is constantly drawing down its NAD+ pool and must regenerate the coenzyme to keep pace — which is where the biosynthesis and recycling pathways come in.

How cells make and recycle NAD+

Cells have more than one way to produce NAD+.

• A de novo ("from scratch") route builds it from the amino acid tryptophan.
• The Preiss-Handler pathway makes it from nicotinic acid, one of the B3 vitamin forms.
• The salvage pathway recycles NAD+ from nicotinamide — the same nicotinamide released when sirtuins, PARPs, and CD38 break the coenzyme down.

In most mammalian tissues, the salvage pathway is understood to be the dominant route, because recycling existing material is more efficient than building the molecule from the beginning each time.

The salvage pathway runs through a short series of enzymatic steps. An enzyme called NAMPT converts nicotinamide into nicotinamide mononucleotide (NMN); this step is generally described as the rate-limiting one, meaning it sets the pace for the whole route. Enzymes called NMNATs then convert NMN into NAD+. The result is a continuous loop: NAD+ is consumed, nicotinamide is released, and the salvage pathway feeds that nicotinamide back toward NAD+ again.

Researchers have described a tendency for NAD+ levels in various tissues to decline with age and under certain metabolic stresses, and have studied the enzymes that both consume and regenerate the coenzyme. That body of research is what has drawn scientific attention to the salvage pathway and to the molecules that feed it. Describing this biology is not the same as claiming that any product changes it in a given person; those are separate questions this article does not answer.

What NMN and NR are

Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are two naturally occurring molecules within the vitamin B3 family, and both sit inside the salvage pathway as intermediates on the way to NAD+. They are closely related in structure. NR is a nicotinamide molecule joined to a ribose sugar. NMN is that same structure with an added phosphate group — in other words, NMN is the phosphorylated form of NR.

That structural relationship places them at different points along the salvage route. NMN sits directly adjacent to NAD+: a single step, carried out by the NMNAT enzymes, separates NMN from NAD+. NR sits one step earlier, before the phosphate group is added to form NMN. Both molecules occur in trace amounts in some foods and are also present inside cells as part of normal NAD+ turnover, rather than being wholly foreign substances.

How the precursors feed the salvage pathway

The reason NMN and NR are described as NAD+ "precursors" is that each can be converted, through the salvage pathway's enzymes, into NAD+. NR is understood to enter cells and then be phosphorylated by enzymes called nicotinamide riboside kinases (NRK1 and NRK2), which add the phosphate group that turns NR into NMN. From there, the NMNAT enzymes convert NMN into NAD+. In short, the studied route for NR runs NR to NMN to NAD+.

NMN, already carrying the phosphate group, sits one step closer to NAD+ and is understood to be converted directly by NMNAT. Exactly how NMN crosses the cell membrane has been an active area of research: some studies point to a dedicated transporter, while others describe NMN being converted to NR at the cell surface and then rebuilt into NMN inside the cell. These transport details remain a subject of ongoing scientific investigation and are one reason the two precursors are studied side by side.

What NMN and NR share is the same underlying logic: both supply substrate to the salvage pathway that regenerates NAD+. Whether, where, and to what degree a given intake changes NAD+ levels in specific human tissues is a scientific question that continues to be studied, and it is not something this article claims to settle. NMN and NR are also encountered in different forms and regulatory categories — including compounded preparations, which are not FDA-approved products — and how any particular preparation should be classified or used is not a determination to make from a general explainer.

How prescription review works on OpenDoseRx

OpenDoseRx is built so that a licensed clinician — not the shopper — makes any medical decision. You begin by choosing a product and the specific strength or option you are interested in, then complete a structured medical intake that asks about your health history, current medications, and other relevant information.

That intake is routed to an independent, licensed U.S. provider who reviews it and decides whether a prescription is appropriate for you. If the provider determines it is, the order is sent to a licensed U.S. pharmacy that fills and ships it. If the provider declines, the order does not proceed and you are not charged for the medication — you receive a full refund. This process is educational and procedural, not medical advice, and nothing here replaces a conversation with your own healthcare provider.